Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Cyclin-Dependent Kinases (CDK) Signaling Blockade Potentiates NK Cell Mediated Cytotoxicity Against Acute Myelogenous Leukemia

Hyun Don Yun, MD, Dawn Schirm, Martin Felices, PhD, Jeffrey S. Miller, MD, Craig E. Eckfeldt, MD PhD

Blood (2018) 132 (Supplement 1): 4538.

https://doi.org/10.1182/blood-2018-99-113004

Published: 2018

Journal Articles

Non-Inferior Clinical Outcomes for Lymphoma and Myeloma Patients Referred from a County Hospital to an Academic Transplant Center for Autologous Stem Cell Transplantation

Hyun Don Yun, MD, Tehseen Dossul, BA, Leon Bernal-Mizrachi, MD, Jeffrey Switchenko, PhD, Chukwuma Ndibe, MD, Abiola Ibraheem, MD, Amelia Langston, MD, Rebecca Pentz, PhD, Edmund K. Waller, MD PhD

Blood (2014) 124 (21): 6002.

https://doi.org/10.1182/blood.V124.21.6002.6002

Published: 2014

Journal Articles

VIP-Receptor Antagonist Enhanced Antileukemic Activity In Mice

Jian-Ming Li, Ph.D, Christopher Thomas Petersen, Graduate, Katarzyna Anna Darlak, Graduate, Hyun Don Yun, MD, Bruce R Blazar, MD, Edmund K. Waller, MD, PhD

Blood (2013) 122 (21): 1664.

https://doi.org/10.1182/blood.V122.21.1664.1664

Published: 2013

Journal Articles

Smudge cells following treatment with pentostatin in a patient with B-cell prolymphocytic leukemia

Hyun Don Yun, Edmund K. Waller

Blood (2013) 122 (4): 474.

https://doi.org/10.1182/blood-2013-02-481697

Published: 2013

Journal Articles

Blockade of VIP-Signaling Enhanced Anti-Leukemic Activity in Murine Allogeneic BMT without Significantly Increased GvHD.

Jian-Ming Li, PhD, Hyun Don Yun, Edmund K. Waller, MD, PhD

Blood (2012) 120 (21): 3001.

https://doi.org/10.1182/blood.V120.21.3001.3001

Published: 2012

Journal Articles

Escalation Trial of Clofarabine Followed by Escalating Dose of Fractionated Cyclophosphamide in Adults with Relapsed or Refractory Acute Leukemias,

Amer M. Zeidan, MD, Hetty E Carraway, MD, MBA, Hyun Don Yun, MD, Jacqueline M Greer, RN, Judith E. Karp, MD

Blood (2011) 118 (21): 3615.

https://doi.org/10.1182/blood.V118.21.3615.3615

Published: 2011

NARROW

Cyclin-Dependent Kinases (CDK) Signaling Blockade Potentiates NK Cell Mediated Cytotoxicity Against Acute Myelogenous Leukemia

Non-Inferior Clinical Outcomes for Lymphoma and Myeloma Patients Referred from a County Hospital to an Academic Transplant Center for Autologous Stem Cell Transplantation

VIP-Receptor Antagonist Enhanced Antileukemic Activity In Mice

Smudge cells following treatment with pentostatin in a patient with B-cell prolymphocytic leukemia

Blockade of VIP-Signaling Enhanced Anti-Leukemic Activity in Murine Allogeneic BMT without Significantly Increased GvHD.

Escalation Trial of Clofarabine Followed by Escalating Dose of Fractionated Cyclophosphamide in Adults with Relapsed or Refractory Acute Leukemias,

Email alerts

ASH Publications

American Society of Hematology

Cyclin-Dependent Kinases (CDK) Signaling Blockade Potentiates NK Cell Mediated Cytotoxicity Against Acute Myelogenous Leukemia

Non-Inferior Clinical Outcomes for Lymphoma and Myeloma Patients Referred from a County Hospital to an Academic Transplant Center for Autologous Stem Cell Transplantation

VIP-Receptor Antagonist Enhanced Antileukemic Activity In Mice

Smudge cells following treatment with pentostatin in a patient with B-cell prolymphocytic leukemia

Blockade of VIP-Signaling Enhanced Anti-Leukemic Activity in Murine Allogeneic BMT without Significantly Increased GvHD.

Escalation Trial of Clofarabine Followed by Escalating Dose of Fractionated Cyclophosphamide in Adults with Relapsed or Refractory Acute Leukemias,

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only